These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. II. Influence of medication with prednisone and azathioprine: a histologic and immunohistologic study at the light microscopic and the ultrastructural level. Feenstra K; van den Lee R; Greben HA; Arends A; Hoedemaeker PJ Lab Invest; 1975 Feb; 32(2):243-50. PubMed ID: 1089843 [TBL] [Abstract][Full Text] [Related]
7. Fucoidan inhibits the development of proteinuria in active Heymann nephritis. Zhang Q; Li N; Zhao T; Qi H; Xu Z; Li Z Phytother Res; 2005 Jan; 19(1):50-3. PubMed ID: 15799003 [TBL] [Abstract][Full Text] [Related]
8. Effect of reimmunization with Fx1A late in the course of Heymann nephritis. Noble B; Van Liew JB; Brentjens JR; Andres GA Lab Invest; 1982 Nov; 47(5):427-36. PubMed ID: 6752571 [TBL] [Abstract][Full Text] [Related]
9. Cyclosporin A prevents proteinuria in an active model of membranous nephropathy in rats. Thaiss F; Schoeppe W; Willaredt-Stoll JG; Batsford S; Mihatsch MJ Lab Invest; 1989 Dec; 61(6):661-9. PubMed ID: 2689773 [TBL] [Abstract][Full Text] [Related]
10. Absence of an anaphylactic vasopermeability mechanism for immune complex deposition in the Heymann nephritis of rats. Egido J; Alonso F; Sanchez Crespo M; Barat A; Hernando L Clin Exp Immunol; 1980 Oct; 42(1):99-106. PubMed ID: 6161727 [TBL] [Abstract][Full Text] [Related]
11. Passive Heymann nephritis with acute and severe proteinuria induced by heterologous antibody against renal tubular brush border glycoprotein gp108. Natori Y; Hayakawa I; Shibata S Lab Invest; 1986 Jul; 55(1):63-70. PubMed ID: 3755192 [TBL] [Abstract][Full Text] [Related]
12. Effects of a new immunosuppressive agent, FK506, in rats with active Heymann nephritis. Matsukawa W; Hara S; Yoshida F; Suzuki N; Fukatsu A; Yuzawa Y; Sakamoto N; Matsuo S J Lab Clin Med; 1992 Feb; 119(2):116-23. PubMed ID: 1371298 [TBL] [Abstract][Full Text] [Related]
13. Autologous immune complex nephropathy. I. Sequential study of immune complex deposition, ultrastructural changes, proteinuria, and alterations in glomerular sialoprotein. Couser WG; Stilmant MM; Darby C Lab Invest; 1976 Jan; 34(1):23-30. PubMed ID: 1246122 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibition prevents loss of glomerular hydraulic permeability in passive heymann nephritis. Remuzzi A; Monaci N; Bonassi ME; Corna D; Zoja C; Mohammed EI; Remuzzi G Lab Invest; 1999 Dec; 79(12):1501-10. PubMed ID: 10616201 [TBL] [Abstract][Full Text] [Related]
15. A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis. Levidiotis V; Freeman C; Punler M; Martinello P; Creese B; Ferro V; van der Vlag J; Berden JH; Parish CR; Power DA J Am Soc Nephrol; 2004 Nov; 15(11):2882-92. PubMed ID: 15504941 [TBL] [Abstract][Full Text] [Related]
16. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis. Makker SP; Tramontano A J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232 [TBL] [Abstract][Full Text] [Related]
17. Receptor antagonist of platelet activating factor inhibits inflammatory injury induced by in situ formation of immune complexes in renal glomeruli and in the skin. Camussi G; Pawlowski I; Saunders R; Brentjens J; Andres G J Lab Clin Med; 1987 Aug; 110(2):196-206. PubMed ID: 2955066 [TBL] [Abstract][Full Text] [Related]